• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Allara Health Raises $26M to Expand Virtual Care for Women with Chronic Hormonal Conditions

by Jasmine Pennic 01/27/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– Allara Health, a virtual care platform addressing the unique needs of women with chronic hormonal conditions secures $26M in a Series B funding round led by Index Ventures, with participation from existing investor GV (Google Ventures). 

– The latest funding brings Allara’s total raised to $38.5M and will fuel the company’s mission to provide accessible, comprehensive care for women across the United States.

Impact of Chronic Hormonal Conditions

Chronic hormonal conditions, such as polycystic ovary syndrome (PCOS), endometriosis, and hypothyroidism, affect millions of women, often causing significant health challenges and impacting their quality of life. However, diagnosis and access to quality care can be difficult. Studies show that many women with these conditions face long delays in diagnosis and often feel dismissed by their healthcare providers.

Allara Health is bridging this care gap by providing a virtual platform that connects women with a multidisciplinary team of experts, including OB-GYNs, endocrinologists, nurse practitioners, and registered dietitians. Allara’s whole-body approach to care combines medical expertise, lifestyle management, and community support to create personalized treatment plans that address the unique needs of each individual.

Addressing a Significant Need

Allara Health’s virtual care platform addresses a critical need in women’s healthcare. With 1 in 3 women experiencing a chronic hormonal condition in their lifetime, the demand for specialized care is significant. Allara’s platform provides:

  • Expert medical care: Access to a multidisciplinary team of specialists who understand the complexities of hormonal conditions.
  • Personalized treatment plans: Tailored care plans that address individual needs and goals.
  • Lifestyle management support: Guidance on nutrition, exercise, and stress management to improve overall health and well-being.
  • Community support: A supportive online community where women can connect with others facing similar challenges.

Investing in Clinical Leadership

Allara has also strengthened its clinical leadership with the appointment of Dr. Heather Huddleston as Chief Medical Officer. Dr. Huddleston is a renowned specialist in reproductive endocrinology and infertility, bringing deep expertise to Allara’s care model.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Femtech, Virtual Care

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Kinetik CEO Sufian Chowdhury on Fighting NEMT Fraud & Waste

Most-Read

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

'Cranky Index' Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

‘Cranky Index’ Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

Madison Dearborn Partners to Acquire Significant Stake in NextGen Healthcare

Madison Dearborn Partners to Acquire Significant Stake in NextGen Healthcare

Wandercraft Begins Clinical Trials for Physical AI-Powered Personal Exoskeleton

Wandercraft Begins Clinical Trials for Physical AI-Powered Personal Exoskeleton

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |